Abstract | PURPOSE: METHODS: Fifty-one untreated patients with OSA and 42 non-OSA controls were recruited. Plasma PSGL-1 levels were determined in evening and morning samples, P-selectin levels were analyzed in morning samples using commercially available ELISA kits. Polysomnography was performed in all participants. OSA was defined by an apnea-hypopnea index ≥ 5/h. RESULTS: PSGL-1 levels did not differ between controls and OSA patients either in the evening or in the morning. Although, there was no difference between controls (16.9/6.8-40.8 ng/ml) and patients with OSA (19.6/8.4-56.8, p = 0.24), patients with severe OSA had increased plasma P-selectin levels (25.6/8.4-56.8 ng/ml) compared to mild OSA patients (14.1/8.5-35.3 ng/ml, p = 0.006) and controls (p = 0.03). CONCLUSIONS:
P-selectin expression relates to disease severity suggesting a pathophysiological role in endothelial cell activation. PSGL-1 levels are unaltered in OSA, suggesting an alternative activation pathway for P-selectin in OSA.
|
Authors | P Horváth, Z Lázár, G Gálffy, R Puskás, L Kunos, Gy Losonczy, M Mészáros, Á D Tárnoki, D L Tárnoki, A Bikov |
Journal | Lung
(Lung)
Vol. 198
Issue 1
Pg. 173-179
(02 2020)
ISSN: 1432-1750 [Electronic] United States |
PMID | 31897593
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Membrane Glycoproteins
- P-Selectin
- P-selectin ligand protein
|
Topics |
- Adult
- Aged
- Case-Control Studies
- Female
- Humans
- Inflammation
- Male
- Membrane Glycoproteins
(blood)
- Middle Aged
- P-Selectin
(blood)
- Polysomnography
- Sleep Apnea, Obstructive
(blood)
|